PCN22 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED GASTRIC CANCER IN CHINA
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)73114-X
https://www.valueinhealthjournal.com/article/S1098-3015(11)73114-X/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
1276
First Page :
A514
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73114-X&doi=10.1016/S1098-3015(11)73114-X